Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19800439rdf:typepubmed:Citationlld:pubmed
pubmed-article:19800439lifeskim:mentionsumls-concept:C1265386lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0205466lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0008109lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0017387lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0043046lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0332161lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:19800439lifeskim:mentionsumls-concept:C0392760lld:lifeskim
pubmed-article:19800439pubmed:issue52lld:pubmed
pubmed-article:19800439pubmed:dateCreated2009-12-1lld:pubmed
pubmed-article:19800439pubmed:abstractTextThe present study describes the effects of a commercially available genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) on clinical, pathological and virological features in three multi-site farms suffering from postweaning multisystemic wasting syndrome (PMWS). The vaccine product was able to reduce clinical signs, PCV2 viral load in lymphoid organs and/or sera, and overall mortality in nurseries and fattening units. This is the first time in which is shown that a PCV2 vaccine is able to decrease specifically PMWS-associated mortality. Another novelty of this study is the assessment of PMWS-like histological lesions in a large number of vaccinated and non-vaccinated pigs under field conditions.lld:pubmed
pubmed-article:19800439pubmed:languageenglld:pubmed
pubmed-article:19800439pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19800439pubmed:citationSubsetIMlld:pubmed
pubmed-article:19800439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19800439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19800439pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19800439pubmed:statusMEDLINElld:pubmed
pubmed-article:19800439pubmed:monthDeclld:pubmed
pubmed-article:19800439pubmed:issn1873-2518lld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:XuZZlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:FraileLLlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:AlegreAAlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:SegalésJJlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:CrisciEElld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:BruTTlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:UrnizaAAlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:BalaschMMlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:Plana-DuranJJlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:NofraríasMMlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:SibilaMMlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:López-SoriaSSlld:pubmed
pubmed-article:19800439pubmed:authorpubmed-author:ChuH-JHJlld:pubmed
pubmed-article:19800439pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19800439pubmed:day9lld:pubmed
pubmed-article:19800439pubmed:volume27lld:pubmed
pubmed-article:19800439pubmed:ownerNLMlld:pubmed
pubmed-article:19800439pubmed:authorsCompleteYlld:pubmed
pubmed-article:19800439pubmed:pagination7313-21lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:meshHeadingpubmed-meshheading:19800439...lld:pubmed
pubmed-article:19800439pubmed:year2009lld:pubmed
pubmed-article:19800439pubmed:articleTitleA genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms.lld:pubmed
pubmed-article:19800439pubmed:affiliationCentre de Recerca en Sanitat Animal, UAB-IRTA, Campus de la Universitat, Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain. joaquim.segales@uab.catlld:pubmed
pubmed-article:19800439pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19800439lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19800439lld:pubmed